BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 34 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $360 | -64.0% | 500 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 496,756 | $1,451,000 | 0.10% |
| AJU IB Investment Co., Ltd. | 25,651 | $75,000 | 0.05% |
| BOOTHBAY FUND MANAGEMENT, LLC | 49,797 | $145,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $38,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $727,000 | 0.00% |
| Tekla Capital Management LLC | 6,000 | $18,000 | 0.00% |
| Orion Capital Management LLC | 500 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,673 | $10,000 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $32,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |